Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Untangling the Complexity of Childhood Atopic Dermatitis: Phenotypes and Endotypes.

Clinical reviews in allergy & immunology·2026
Same author

Treatment Strategies for Prevention of Atopic Dermatitis.

Immunology and allergy clinics of North America·2025
Same author

S. aureus exposure during cutaneous antigen sensitization causes basophil- and interleukin-4-dependent exaggerated food anaphylaxis.

Immunity·2025
Same author

Response to: "Response to Bissonnette et al. Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy control-matched, phase 4 clinical study (BALISTAD)".

Journal of the American Academy of Dermatology·2025
Same author

Response to Chang et al's "Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis".

Journal of the American Academy of Dermatology·2025
Same author

Lipidomic Analysis of Esophageal Epithelia Reveals a Distinctive Sphingolipid Profile in Eosinophilic Esophagitis.

Allergy·2025
Same journal

Transient B cell lymphopenia revealed by KRECs newborn screening: Post-screening referral strategies, clinical course, and follow-up.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Phenotypes of atopic dermatitis in Polish children-Latent class analysis of cross-sectional questionnaire-based study.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Comment on Elhani et al.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Bridging Rare to Common Diseases: Precision Medicine and the Transforming Landscape of Pediatric Allergy and Immunology.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Involution of IgE sensitization to house dust mite allergen molecules by age.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Early initiation of inhaled corticosteroid-long-acting β<sub>2</sub>-agonist therapy and reduction of severe asthma exacerbations in high-risk preschool children: A longitudinal real-world cohort study.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
See all related articles

Related Experiment Video

Updated: Jan 16, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.6K

Predictive biomarkers for atopic dermatitis.

Jessica W Hui-Beckman1, Elena Goleva1, Donald Y M Leung1

  • 1Department of Pediatrics, National Jewish Health, Denver, Colorado, USA.

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|October 3, 2025
PubMed
Summary
This summary is machine-generated.

Identifying early preclinical biomarkers for atopic dermatitis (AD) in infants is crucial for prevention and early treatment. Research shows skin barrier components, immune markers, and microbiome changes precede clinical AD diagnosis.

Keywords:
atopic dermatitisbiomarkersbirth cohortsskin barrier dysfunction

More Related Videos

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation
02:36

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

1.6K
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.1K

Related Experiment Videos

Last Updated: Jan 16, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.6K
Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation
02:36

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

1.6K
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.1K

Area of Science:

  • Dermatology and immunology research.
  • Pediatric health and disease prevention.

Background:

  • Atopic dermatitis (AD) is a common inflammatory skin condition.
  • Early detection of AD risk factors is essential for timely intervention.
  • Understanding preclinical markers can guide preventative strategies.

Purpose of the Study:

  • To review the skin barrier structure.
  • To identify early-life preclinical biomarkers for atopic dermatitis (AD).
  • To inform strategies for preventing AD development and reducing severity.

Main Methods:

  • Review of global birth cohort studies.
  • Analysis of skin barrier components (lipids, proteins).
  • Evaluation of immunologic markers (cytokines) and microbiome alterations.

Main Results:

  • Preclinical biomarkers for AD exist in at-risk infants.
  • Skin barrier defects, immune dysregulation, and microbiome changes are identified.
  • These alterations are detectable before clinical AD diagnosis.

Conclusions:

  • Early-life biomarkers offer potential for AD prevention.
  • Targeting these markers can lead to early therapeutic interventions.
  • Further research into preclinical AD markers is warranted for improved pediatric skin health.